Minnesota HF 284: Insulin products sold in Minnesota cost review authorized by commissioner of health, excessive cost determined, maximum level of reimbursement established for insulin products if necessary, and money appropriated.

Status: Author added Bierman (as of 2019-04-01)

State: Minnesota · Session: 2019-2020 · Bill: HF 284

Subjects: Health and Health Department

Sponsors: Halverson, Bierman, Brand, Cantrell, Dehn, Elkins, Howard, Huot, Kunesh-Podein, Loeffler, Mann, Persell, Richardson, Schultz, Vang

View Minnesota HF 284 on LegisTrack → — full text, sponsors, votes, campaign finance, and cross-state matches.